Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Invested Capital (2016 - 2026)

Biomerica's Invested Capital history spans 16 years, with the latest figure at $3.3 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 40.06% to $3.3 million in Q1 2026 year-over-year; TTM through Feb 2026 was $3.3 million, a 40.06% decrease, with the full-year FY2025 number at $4.1 million, down 37.72% from a year prior.
  • Invested Capital hit $3.3 million in Q1 2026 for Biomerica, down from $4.4 million in the prior quarter.
  • Over the last five years, Invested Capital for BMRA hit a ceiling of $11.7 million in Q2 2023 and a floor of $3.3 million in Q1 2026.
  • Historically, Invested Capital has averaged $7.0 million across 5 years, with a median of $6.6 million in 2024.
  • Biggest five-year swings in Invested Capital: skyrocketed 40.83% in 2023 and later tumbled 50.35% in 2024.
  • Tracing BMRA's Invested Capital over 5 years: stood at $7.2 million in 2022, then increased by 29.53% to $9.4 million in 2023, then crashed by 45.5% to $5.1 million in 2024, then fell by 13.28% to $4.4 million in 2025, then fell by 25.21% to $3.3 million in 2026.
  • Business Quant data shows Invested Capital for BMRA at $3.3 million in Q1 2026, $4.4 million in Q4 2025, and $5.2 million in Q3 2025.